Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent Clostridioides difficile Infection in Older Adults With Underlying Comorbidities

BACKGROUND: Advanced age and underlying comorbidities are associated with greater rates of recurrence in patients with Clostridioides difficile infection (CDI). Reducing the likelihood of recurrence through treatment with an antimicrobial followed by a microbiota replacement therapy can decrease the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tillotson, Glenn, Archbald-Pannone, Laurie, Johnson, Stuart, Ng, Samson, Ando, Masakazu, Harvey, Adam, Bancke, Lindy, Feuerstadt, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846189/
https://www.ncbi.nlm.nih.gov/pubmed/36686631
http://dx.doi.org/10.1093/ofid/ofac703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846189/
https://www.ncbi.nlm.nih.gov/pubmed/36686631
http://dx.doi.org/10.1093/ofid/ofac703

Ejemplares similares